Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02563574 · ClinicalTrials.gov registry record · NA
ARCH II Study (Alcohol Research Center on HIV Study II)
A NA study of HIV and Alcohol Consumption, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 2
- Study locations
NCT02563574: Completed NA study of HIV and Alcohol Consumption, sponsored by University of Florida.
NCT02563574 is a NA study of HIV and Alcohol Consumption that has completed, run by University of Florida. The registered enrollment target is 14 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02563574, a NA study of HIV and Alcohol Consumption, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is being done to learn about the interaction of alcohol consumption and HIV on brain function. The proposed study will have two broad objectives. The first is to incorporate functional neuroimaging (FMRI) approaches, along with additional Magnetic Resonance Spectroscopy (MRS) methods that will enable a delineation in both functional and cerebral metabolic disturbances affecting specific functional brain systems that are associated with the interaction of ethanol (ETOH) consumption on Human Immunodeficiency Virus (HIV)-associated brain dysfunction. Recent data indicate that HIV infected patients with heavy ETOH consumption have FMRI abnormalities and exhibit alterations on other neuroimaging measures compared to moderate drinkers and people who do not drink at all. The second objective is to examine the extent to which reductions in ETOH consumption among heavy drinkers with HIV infection result from a motivational intervention. The findings from this study will provide important information on how heavy ETOH and HIV interact to affect the brain functional responsiveness, and the extent of improvement that might be gained by reducing heavy ETOH use.
Primary Outcome
Cerebral metabolite abnormalities
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing
- OTHER Blood specimens
- OTHER Questionnaire assessment
- OTHER Neurocognitive assessments
Study Locations (2)
Florida
- University of Florida - Gainesville
- Florida International University - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-12 |
| Est. Completion | 2021-12-16 |
| Phase | NA |
What the finished NCT02563574 record still lists
NCT02563574 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 4 interventions - of which Motivational Interviewing is the first listed.
NCT02563574 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02563574 about?
NCT02563574 is a clinical study titled "ARCH II Study (Alcohol Research Center on HIV Study II)". This study is being done to learn about the interaction of alcohol consumption and HIV on brain function. The proposed study will have two broad objectives. The first is to incorporate functional neuroimaging (FMRI) approaches, along with additional Magnetic Resonance Spectroscopy (MRS) methods that...
What is the current status of trial NCT02563574?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-12. Estimated completion is 2021-12-16.
What conditions does trial NCT02563574 study?
This clinical trial studies the following conditions: HIV, Alcohol Consumption, Motivation.
What interventions are being tested in trial NCT02563574?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Blood specimens (OTHER), Questionnaire assessment (OTHER), Neurocognitive assessments (OTHER).
Who is sponsoring clinical trial NCT02563574?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02563574 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02563574's enrollment target sits among peer trials
14 290th of 303 higher than 12 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia